Evidence map›Paper›PMID 31123171›Full record

ArticleBioscience reports2019

Association of

Chunlei Zhou, Yingzi Tang, Jinhong Zhu, Lili He, Jinghang Li, Yizhen Wang, Haixia Zhou, Jing He, Haiyan Wu

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Effect ofTechnology in cancer research & treatment
    Pooled it
  2. Journal of Cancer · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Chunlei ZhouDepartment of Pathology, Children's Hospital of Nanjing Medical University, Nanjing 210008, Jiangsu, China.
Yingzi TangDepartment of Pathology, Children's Hospital of Nanjing Medical University, Nanjing 210008, Jiangsu, China.
Jinhong ZhuDepartment of Clinical Laboratory, Molecular Epidemiology Laboratory, Harbin Medical University Cancer Hospital, Harbin 150040, Heilongjiang, China.
Lili HeDepartment of Pathology, Children's Hospital of Nanjing Medical University, Nanjing 210008, Jiangsu, China.
Jinghang LiDepartment of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China.
Yizhen WangDepartment of Pathology, Anhui Provincial Children's Hospital, Hefei 230051, Anhui, China.
Haixia ZhouDepartment of Hematology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, Zhejiang, China.
Jing HeDepartment of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, Guangdong, China nchwhy@163.com hejing198374@gmail.com.ORCID 0000-0002-1954-2892
Haiyan WuDepartment of Pathology, Children's Hospital of Nanjing Medical University, Nanjing 210008, Jiangsu, China nchwhy@163.com hejing198374@gmail.com.
Second Affiliated Hospital of Nanjing Medical University · CNAnhui Provincial Children's Hospital · CNGuangzhou Medical University · CNHarbin Medical University · CNJiangsu Province Hospital · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroblastoma is one of the most common malignancy in childhood, which originates from the developing sympathetic nervous system. Single nucleotide polymorphisms (SNPs) in primary miRNA (pri-miRNA) have shown to associate with cancer susceptibility, including neuroblastoma. Three precursor miRNA (pre-miRNA) SNPs (

Indexed as

Genetic Predisposition to DiseaseAge FactorsChild, PreschoolFemaleGenetic Association StudiesGenotypeHumansInfantInfant, NewbornMaleMicroRNAsNeuroblastomaPolymorphism, Single NucleotideRisk FactorsSex CharacteristicsMicroRNAsMIRN146 microRNA, humanMIRN149 microRNA, humanMIRN196 microRNA, humanNeuroblastomapolymorphismspre-miRNAssusceptibility

Identifiers

PMID31123171
PMCPMC6554217
OpenAlexW2946098682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.